Présentation

Contact
Claude Griscelli est professeur de médecine, pédiatre et immunologue. Il a été Directeur général de l'INSERM président de l'Institut des Maladies Génétiques Imagine.
De 1976, Il est nommé chef de service d'immunologie pédiatrique à l'hôpital Necker-Enfants malades. Il est spécialisé en immunologie pédiatrique qui englobe les diverses maladies du système immunitaire, notamment les déficits héréditaires ou acquis, les maladies autoimmunes et les maladies inflammatoires de l'enfant et de l'adolescent. En 1996, il est nommé directeur général de l’Inserm en juillet 1996.
Il crée en 2007 l'institut des maladies génétiques Imagine.
Ressources & publications
-
Journal (source)Blood Adv
Gene transfer into hematopoietic stem cells reduces HLH manifestations in a m...
-
Journal (source)Haematologica
Extensive multilineage analysis in patients with mixed chimerism after alloge...
-
Journal (source)Blood
Lentiviral and genome-editing strategies for the treatment of β-hemoglobinopa...
-
Journal (source)Hum. Mol. Genet.
Gene therapy of hemoglobinopathies: progress and future challenges.
-
Journal (source)Nat Rev Drug Discov
Gene therapy targeting haematopoietic stem cells for inherited diseases: prog...
-
Journal (source)Mol Ther Methods Clin Dev
A Nontoxic Transduction Enhancer Enables Highly Efficient Lentiviral Transduc...
-
Journal (source)Haematologica
Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem ...
-
Journal (source)J. Allergy Clin. Immunol.
Generation of adult human T-cell progenitors for immunotherapeutic applications.
-
Journal (source)Hum. Gene Ther.
Gene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?
-
Journal (source)Stem Cells Dev.
Gene Therapy with Hematopoietic Stem Cells: The Diseased Bone Marrow's Point ...
-
Journal (source)Blood
Gene-corrected human Munc13-4-deficient CD8+ T cells can efficiently restrict...
-
Journal (source)J. Clin. Invest.
Loss of ARHGEF1 causes a human primary antibody deficiency.
-
Journal (source)Haematologica
Mutations in the adaptor-binding domain and associated linker region of p110δ...
-
Journal (source)J. Allergy Clin. Immunol. 2017
Clinical and immunologic phenotype associated with activated phosphoinositide...
-
Journal (source)J. Clin. Invest.
A human immunodeficiency caused by mutations in the PIK3R1 gene.
-
Journal (source)J. Allergy Clin. Immunol.
X-linked primary immunodeficiency associated with hemizygous mutations in the...
-
Journal (source)Blood Adv
Gene transfer into hematopoietic stem cells reduces HLH manifestations in a m...
-
Journal (source)Cell Death Dis
AK2 deficiency compromises the mitochondrial energy metabolism required for d...
-
Journal (source)Stem Cells
Human T-lymphoid progenitors generated in a feeder-cell-free Delta-like-4 cul...
-
Journal (source)Blood
Clonal tracking in gene therapy patients reveals a diversity of human hematop...
-
Journal (source)Haematologica
A gain-of-function RAC2 mutation is associated with bone-marrow hypoplasia an...
-
Journal (source)Blood
Clonal tracking in gene therapy patients reveals a diversity of human hematop...
-
Journal (source)J Immunol
Seletalisib for Activated PI3Kδ Syndromes: Open-Label Phase 1b and Extension ...
-
Journal (source)Front Immunol
Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-K...
-
Journal (source)Mol Ther Methods Clin Dev
Successful Preclinical Development of Gene Therapy for Recombinase-Activating...
-
Journal (source)Mol Ther Methods Clin Dev
Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene T...
-
Journal (source)Front Immunol
Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-K...
-
Journal (source)Blood Adv
Baboon envelope LVs efficiently transduced human adult, fetal, and progenitor...
-
Journal (source)Blood
A combination of cyclophosphamide and interleukin-2 allows CD4+ T cells conve...
-
Journal (source)Blood
Reticular dysgenesis: international survey on clinical presentation, transpla...
-
Journal (source)J Allergy Clin Immunol
An in vivo genetic reversion highlights the crucial role of Myb-Like, SWIRM, ...
-
Journal (source)J Allergy Clin Immunol
The BLNK adaptor protein has a nonredundant role in human B-cell differentiat...
-
Journal (source)J Allergy Clin Immunol
Successful RAG1-SCID gene therapy depends on the level of RAG1 expression.
-
Journal (source)J Allergy Clin Immunol
Recombination-activating gene 1 (Rag1)-deficient mice with severe combined im...
-
Journal (source)Bone Marrow Transplant
Ex vivo generated human T-lymphoid progenitors as a tool to accelerate immune...
-
Journal (source)Stem Cells Dev
Gene Therapy with Hematopoietic Stem Cells: The Diseased Bone Marrow's Point ...
-
Journal (source)JAMA
Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndr...
-
Journal (source)Am J Transplant
Donor-targeted serotherapy as a rescue therapy for steroid-resistant acute GV...
-
Journal (source)Nat Immunol
Single-cell analysis of FOXP3 deficiencies in humans and mice unmasks intrins...
-
Journal (source)Cell Mol Immunol
A DL-4- and TNFα-based culture system to generate high numbers of nonmodified...
-
Journal (source)Nat Commun
Transient mTOR inhibition rescues 4-1BB CAR-Tregs from tonic signal-induced d...
-
Journal (source)Nat Med
Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: t...
-
Journal (source)Nat Commun
Base-editing-mediated dissection of a γ-globin cis-regulatory element for the...
-
Journal (source)Mol Ther Nucleic Acids
Novel lentiviral vectors for gene therapy of sickle cell disease combining ge...
-
Journal (source)Annu Rev Genomics Hum Genet
Sickle Cell Disease: From Genetics to Curative Approaches.
-
Journal (source)Blood
Adenine base editor-mediated correction of the common and severe IVS1-110 (G>...
-
Journal (source)Mol Ther
Combination of lentiviral and genome editing technologies for the treatment o...